financetom
Business
financetom
/
Business
/
Revolutionizing Ukraine's Connectivity: VEON, Airspan Join Forces For Cutting-Edge Network Solutions
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Revolutionizing Ukraine's Connectivity: VEON, Airspan Join Forces For Cutting-Edge Network Solutions
Mar 21, 2025 9:46 AM

Veon Ltd. ( VEON ) shares remained relatively flat on Friday following the announcement of a new collaboration with Airspan Networks Holdings LLC.

The partnership, outlined in a Memorandum of Understanding, aims to strengthen Ukraine’s communications infrastructure through innovative network solutions.

Veon ( VEON ) and Airspan will explore technical and commercial synergies to develop resilient networks tailored to Ukraine's needs.

The collaboration will focus on Open RAN and Air-to-Land solutions, which are designed to enhance network resilience, particularly in extreme conditions. Both companies will also work together to identify business opportunities in public and private sectors.

Veon ( VEON ), together with its subsidiary Kyivstar, has committed to investing $1 billion from 2023 to 2027 to rebuild Ukraine's digital infrastructure.

Also Read: Fed’s Goolsbee Urges Patience As Trump’s Tariffs Stir Fears Of Stagflation: ‘We Need To Be Careful When You Say Transitory’

This initiative includes upgrading and expanding mobile networks with advanced technologies like Open RAN and satellite connectivity.

“We look forward to working with Airspan to explore opportunities as a part of our commitment to the country’s resilience and rebuilding,” said Veon ( VEON ) CEO Kaan Terzioglu.

According to Benzinga Pro, Veon ( VEON ) stock has gained over 97% in the past year.

Earlier this month, the company reported fourth-quarter 2024 sales growth of 4.7% year-over-year to $998 million. Direct digital revenues rose 42.4%, driven by strong growth in Pakistan and Ukraine.

For 2025, Veon ( VEON ) expects underlying local currency revenue YoY growth of 12%–14%, EBITDA growth of 13%–15%, and Capex intensity of 17%–19%.

Price Action: Veon ( VEON ) shares are trading higher by 0.90% to $45.44 at last check Friday.

Read Next:

Micron Technology Posts 2Q Beat: Memory Cyclical Debate Continues, Signs Of Recovery Will Strengthen, Analysts Say

Image: Shutterstock

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved